RxDoctor Payments Data

David Zirkle, DO

Family Medicine · Colorado Springs, CONPI 1366424699

Payments from drug & device makers

$749in general payments, 2019–2025

Across 35 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ironshore Pharmaceuticals Inc.$191
  • Novartis$84
  • Novo Nordisk$75
  • GSK$62
  • Teva Pharmaceuticals USA, Inc.$47
  • Merck$44
  • plus $246 from 10 others

What the payments were for

  • Food & beverage$749100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$749 in reported general payments places this provider in the 75th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$41,181
Medicare patients
168
Services billed
416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide21$27,388
EliquisApixaban12$6,706
SynthroidLevothyroxine Sodium33$2,182
Levothyroxine Sodium149$1,885
Rosuvastatin Calcium89$1,482
Albuterol Sulfate HfaAlbuterol Sulfate39$1,180
Atorvastatin Calcium116$1,045
Montelukast Sodium46$845
Omeprazole44$780
Gabapentin36$773
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$715
Zolpidem Tartrate79$664
Pravastatin Sodium57$654
Lisinopril90$638
Bupropion XlBupropion Hcl14$637

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$40$2,18233 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →